Interventions in the second stage – local anaesthetic spray

Bibliographic reference Study type Evidence level Number of women Women’s characteristics Intervention Comparison Length of follow-up Outcome measures Effect size Source of funding Additional comments
Sanders, Peters & Campbell 2006349RCT1+Intervention group n=93 Control group n=92Women in second stage of labour with no labour complications and without epidural.Lidocaine spray to perineum when birth thought to be imminentApplication of placebo spray1 week PNMain outcome: Pain during birth

Secondary outcomes: Vaginal trauma Neonatal resuscitation Women’s feelings during birth Perineal trauma
Pain during birth (mean (SD):
lidocaine: 76.9 (21.6) vs. placebo 72.1 (22.2), difference between means 4.8 (−1.7 to 11.2), p=0.14.
Adjustmenting for the differences between trial groups: 6.3 (−0.8 to 13.3), p=0.081.
Most secondary outcomes were similar between groups including: vaginal trauma, neonatal resuscitation, feelings during birth, overall rating of birth experience, sutured after birth and perineal pain 1 week after birth.
There was a significantly lower incidence of 2nd degree perineal trauma in the lidocaine group: 28.0% vs. 44.6%, RR 0.63 (95% CI 0.42 to 0.93), p=0.019.
Women in the lidocaine spray group were also less likely to report dyspareunia on resumption of sexual intercourse L 27.1% vs. 52.7%, RR 0.52 (95% CI 0.35 to 0.76), p=0.0004.
Not statedThe authors point out that the large number of secondary analyses undertaken means these differences could be chance findings.

Country: UK

From: Evidence tables

Cover of Intrapartum Care
Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth.
NICE Clinical Guidelines, No. 55.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2007 Sep.
Copyright © 2007, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.